In an inflamed condition, κ-CGN had a stronger effect on cytokine release, with an increase of IL-6, IL-13, IL-2, and IL-4, suggesting that CGN has the potential to maintain or even amplify intestinal inflammation during active IBD. This evidence concerns the gene IL13 and inflammatory bowel disease.